Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes

Citation:

Chatziralli I, Regan SO, Mohamed R, Talks J, Sivaprasad S. Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes. Eye. 2018;32:1523–1529.